NRAV and hepatocellular carcinoma: Firstly, the knockdown of NRAV impeded HCC cell viability, proliferation and invasion, which was partly reversed by the co-transfection of miR-199a-3p inhibitors and sh-NRAV (Figures 5A–5c).